Home Home > Browse Locations > France

Find Paid Clinical Trials in France

Paid Clinical Trials and Focus Groups


Paid Clinical Trials in France

Top of Directory » All Locations » France


  • Prospective Multicentric Study of Cytomegalovirus Resistance in Transplant Patients and Bone Marrow Recipients

    Condition:   Cytomegalovirus
    Intervention:   Biological: depistage
    Sponsor:   University Hospital, Limoges
    Recruiting - verified November 2009

  • Multipolar Radiofrequency Ablation for Hepatocellular Carcinoma Using Extra Nodular Versus Intranodular Technique

    Condition:   Hepatocellular Carcinomas
    Intervention:   Procedure: Radiofrequency ablation
    Sponsor:   Assistance Publique - Hôpitaux de Paris
    Not yet recruiting - verified November 2009

  • A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: tocilizumab;   Drug: tocilizumab;   Drug: methotrexate
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009

  • A Study Comparing LEO 80190 Ointment With Hydrocortisone Ointment, Both Applied Once Daily in the Treatment of Psoriasis Vulgaris on the Face and Intertriginous Areas

    Condition:   Psoriasis Vulgaris
    Interventions:   Drug: LEO 80190;   Drug: Hydrocortisone
    Sponsor:   LEO Pharma
    Recruiting - verified November 2009

  • Low-energy Laser Therapy for Prevention of Oral Mucositis in Children

    Condition:   Oral Mucositis
    Intervention:   Device: LLLT :low level laser therapy
    Sponsors:   University Hospital, Clermont-Ferrand;   - Centre Régional de Cancérologie et Thérapie Cellulaire Pédiatrique, CHU de Clermont-Ferrand;   - Faculté de chirurgie dentaire, Clermont-Ferrand;   - Centre de Pharmacologie Clinique, INSERM CIC 501;   - Laboratoire des Matériaux Inorganiques, ESA CNRS 6002 et ENSCCF, Université Blaise-Pascal, Aubière
    Recruiting - verified November 2009

  • Observational Study of Patient Comprehension, Perception, Fears and Appreciation Following Home-Monitoring Implementation

    Conditions:   Defibrillators;   Tachycardia
    Intervention:   Other: Remote monitoring by Home Monitoring system
    Sponsors:   Biotronik France;   Biotronik SE & Co. KG
    Recruiting - verified November 2009

  • Effect of Omalizumab in Patients With Severe Persistent Non-atopic Uncontrolled Asthma

    Condition:   Asthma
    Interventions:   Drug: Omalizumab;   Drug: Placebo
    Sponsor:   Novartis
    Recruiting - verified November 2009

  • Brain Computer Interface for Communication in ICU: a Feasibility Study

    Conditions:   Tetraplegia;   Guillain-Barre Syndrome
    Intervention:  
    Sponsor:   University of Versailles
    Not yet recruiting - verified October 2009

  • A Study to Determine the Correct Dose of Amikacin Which is Delivered Directly to the Lungs of Ventilated Patients as an Aerosol Via an Investigational Device Called the Pulmonary Delivery Device System (PDDS)

    Condition:   Pneumonia
    Interventions:   Drug: Amikacin (BAY41-6551);   Drug: Amikacin (BAY41-6551);   Drug: Placebo
    Sponsors:   Bayer;   Nektar Therapeutics
    Completed - verified October 2009

  • Safety and Efficacy Study of Kaname Coronary Stent System for the Treatment of Patients With Coronary Artery Disease

    Conditions:   Coronary Artery Disease;   Angioplasty, Transluminal, Percutaneous Coronary
    Intervention:   Device: Kaname cobalt-chromium coronary stent
    Sponsor:   Terumo Europe N.V.
    Not yet recruiting - verified October 2009

  • An Exploratory Study to Assess the Effects of JNJ-39439335 on the Relief of Pain Using a Thermal-Grill Experimental Model

    Condition:   Pain
    Intervention:   Drug: JNJ-39439335, Placebo
    Sponsor:   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
    Not yet recruiting - verified October 2009

  • Phase IIa Study of MP4OX in Hemorrhagic Shock Patients With Lactic Acidosis

    Conditions:   Shock, Hemorrhagic;   Shock, Traumatic;   Acidosis, Lactic
    Interventions:   Drug: MP4OX;   Drug: MP4OX;   Drug: Ringer's Lactate solution
    Sponsor:   Sangart
    Not yet recruiting - verified October 2009

  • Gastric Bypass and Peripheral Activity of the Endocannabinoid System

    Condition:   Obesity
    Interventions:   Biological: Evaluation of the endocannabinoid system;   Procedure: Biopsy of visceral and peripheral adipose tissue;   Biological: Evaluation of metabolic parameters;   Behavioral: Evolution of behavioral parameters;   Behavioral: Dietician consultation;   Behavioral: Psychologist consultation
    Sponsors:   University Hospital, Bordeaux;   Institut National de la Santé Et de la Recherche Médicale, France
    Recruiting - verified November 2009

  • Computerized Glucose Control in Critically Ill Patients

    Conditions:   Hyperglycemia;   Critical Illness
    Interventions:   Device: CGAO-based Glucose Control;   Device: Standard-Care Glucose Control
    Sponsors:   Centre Hospitalier of Chartres;   Société Française d'Anesthésie et de Réanimation (SFAR);   Baxter Healthcare Corporation
    Recruiting - verified November 2009

  • The Occlusive Dressing

    Condition:   Fingertips Traumatic Amputations
    Interventions:   Other: TEGADERM®;   Procedure: Surgery
    Sponsor:   University Hospital, Strasbourg, France
    Not yet recruiting - verified October 2009

  • Effect of Preliminary Administration of Cyclosporine (Sandimmun ®) on Different Markers of Cardiac Ischaemia Induced by Cardiopulmonary Bypass

    Conditions:   Coronary Artery Bypass Surgery;   Cardiopulmonary Bypass
    Interventions:   Drug: Sandimmum;   Drug: Placebo
    Sponsor:   University Hospital, Grenoble
    Recruiting - verified November 2009

  • Rotation or Change of Biotherapy After First Anti-TNF Treatment Failure for Rheumatoid Arthritis

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: infliximab, etanercept, adalimumab;   Drug: abatacept, rituximab or tocilizumab
    Sponsor:   University Hospital, Strasbourg, France
    Not yet recruiting - verified October 2009

  • Efficacy and Safety of Aclidinium Bromide at Two Dose Levels Versus Placebo Administered in Chronic Obstructive Pulmonary Disease (COPD) Patients

    Condition:   Chronic Obstructive Pulmonary Disease
    Interventions:   Drug: Aclidinium bromide;   Drug: Placebo
    Sponsors:   Almirall S.A.;   Forest Laboratories
    Recruiting - verified November 2009

  • A Study Evaluating the Activity, Safety and Pharmacology of Two Doses of IPH2101, a Human Monoclonal Anti-KIR Antibody, in Patients With Multiple Myeloma in Stable Partial Response After a First Line Therapy

    Condition:   Multiple Myeloma
    Intervention:   Drug: IPH2101 Fully human anti-KIR monoclonal antibody
    Sponsor:   Innate Pharma
    Recruiting - verified October 2009

  • Study to Evaluate the Clinical Impact of a Laparoscopic Radical Prostatectomy Simulator

    Conditions:   Prostatic Neoplasms;   Cancer of Prostate;   Prostate Cancer;   Prostate Neoplasms
    Interventions:   Procedure: Laparoscopic Radical Prostatectomy (without a simulator) - no intervention;   Procedure: Laparoscopic Radical Prostatectomy (with a simulator)
    Sponsor:   Assistance Publique - Hôpitaux de Paris
    Not yet recruiting - verified October 2009

  • Using Repetitive Transcranial Magnetic Stimulation (rTMS) in the Rehabilitation of Chronic Spatial Neglect After Stroke

    Conditions:   Cerebrovascular Disorders;   Cerebral Stroke;   Visuo-spatial Neglect;   Visuo-spatial Extinction
    Interventions:   Device: Real rTMS;   Device: Sham rTMS
    Sponsor:   Assistance Publique - Hôpitaux de Paris
    Not yet recruiting - verified October 2009

  • High Dose of Erythropoietin Analogue After Cardiac Arrest

    Condition:   Comatose Survivors of Cardiac Arrest
    Interventions:   Drug: EPOETINE ALPHA;   Other: Control arm
    Sponsor:   Assistance Publique - Hôpitaux de Paris
    Recruiting - verified October 2009

  • A Long-Term Study of Healthy Adults Vaccinated With One Dose of Smallpox Vaccine (LISTER Strain)

    Condition:   Smallpox
    Intervention:  
    Sponsor:   Sanofi-Aventis
    Enrolling by invitation - verified October 2009

  • Dose Escalation Study of Concomitant BIBF 1120 + BIBW 2992 in Patients With Advanced Solid Tumours.

    Condition:   Neoplasms
    Interventions:   Drug: BIBF 1120;   Drug: BIBW 2992;   Drug: 5-FU
    Sponsor:   Boehringer Ingelheim Pharmaceuticals
    Not yet recruiting - verified October 2009

  • Sevoflurane Versus Propofol for Intubation in Neonatal Intensive Care

    Condition:   Endotracheal Intubation
    Interventions:   Drug: Administration of sevoflurane;   Drug: Administration of propofol
    Sponsor:   Assistance Publique Hopitaux De Marseille
    Active, not recruiting - verified November 2009

  • Masitinib in Non Pre-treated, Inoperable Patients With Locally Advanced/Metastatic Gastro-intestinal Stromal Tumour (GIST)

    Condition:   Gastro-intestinal Stromal Tumours
    Intervention:   Drug: oral masitinib
    Sponsor:   AB Science
    Active, not recruiting - verified October 2009

  • N-acetyl-cysteine (NAC) and Kidney Graft Function

    Conditions:   Brain Death;   Chronic Renal Insufficiency
    Intervention:   Drug: N-acetylcysteine
    Sponsor:   Institut d'Anesthesiologie des Alpes Maritimes
    Recruiting - verified October 2009

  • Impact of Adipose Tissue Repartition on the Time Course of Vascular Dysfunction - the NUMEVOX Cohort

    Conditions:   Metabolic Diseases;   Sleep Apnea;   Atherosclerosis
    Intervention:  
    Sponsor:   University Hospital, Angers
    Recruiting - verified October 2009

  • Patterns of Non-Adherence to Dual Anti-Platelet Regimen In Stented Patients

    Conditions:   Medication Non-adherence;   Stent Thrombosis
    Intervention:  
    Sponsors:   Columbia University;   Bristol-Myers Squibb;   Sanofi-Aventis
    Recruiting - verified October 2009

  • Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With Pioglitazone

    Condition:   Diabetes Mellitus, Type 2
    Intervention:   Drug: Linagliptin
    Sponsor:   Boehringer Ingelheim Pharmaceuticals
    Recruiting - verified October 2009

  • Follow-Up Care With or Without CEA Assessments in Patients Who Have Undergone Surgery for Stage II or Stage III Colorectal Cancer

    Condition:   Colorectal Cancer
    Interventions:   Other: diagnostic laboratory biomarker analysis;   Procedure: computed tomography;   Procedure: diagnostic colonoscopy;   Procedure: standard follow-up care;   Procedure: ultrasound imaging
    Sponsor:   Federation Francophone de Cancerologie Digestive
    Recruiting - verified October 2009

  • Dose-Escalation Study of PHA-793887 in Patients With Advanced/Metastatic Solid Tumors

    Condition:   Advanced/Metastatic Solid Tumors
    Intervention:   Drug: PHA-793887
    Sponsor:   Nerviano Medical Sciences
    Terminated - verified October 2009

  • Study to Assess the Efficacy and Safety of Repeated Administration of BIM 23A760 in Patients With Acromegaly

    Condition:   Acromegaly
    Intervention:   Drug: BIM 23A760
    Sponsor:   Ipsen
    Recruiting - verified November 2009

  • Relational Development in Children With Cleft Lips and Palates: Influence of the Waiting Period Prior to the First Surgical Intervention and the Parents' Psychological Perception of the Abnormality

    Condition:   Cleft Palate
    Intervention:  
    Sponsor:   University Hospital, Strasbourg, France
    Not yet recruiting - verified October 2009

  • Study Evaluating Safety, Tolerability and Efficacy of YM150 in Subjects With Acute Coronary Syndromes

    Condition:   Acute Coronary Syndrome
    Interventions:   Drug: YM150;   Drug: Placebo
    Sponsor:   Astellas Pharma Inc
    Recruiting - verified October 2009

  • Safety and Efficacy of AIN457 in Behçet's Patients With Posterior or Panuveitis

    Condition:   Behcet Disease
    Interventions:   Biological: AIN457;   Biological: AIN457;   Biological: Placebo
    Sponsor:   Novartis Pharmaceuticals
    Recruiting - verified October 2009

  • Long-Term Safety and Tolerability of Idebenone in Friedreich's Ataxia Patients (MICONOS Extension)

    Condition:   Freidreich's Ataxia
    Intervention:   Drug: idebenone
    Sponsor:   Santhera Pharmaceuticals
    Enrolling by invitation - verified October 2009

  • Individually Tailored Prophylaxis in Patients With Severe Hemophilia A

    Condition:   Hemophilia A
    Interventions:   Drug: FVIII;   Drug: FVIII
    Sponsor:   Hospices Civils de Lyon
    Recruiting - verified October 2009

  • Preventive Sodium Lactate and Traumatic Brain Injury

    Condition:   Head Trauma
    Interventions:   Drug: half molar sodium lactate;   Drug: isotonic sodium chloride
    Sponsors:   Institut d'Anesthesiologie des Alpes Maritimes;   Medical University of Nice;   Medical University of Grenoble
    Recruiting - verified October 2009

  • Upper Limb Evaluation in Non Ambulatory Patients With Neuromuscular Disorder

    Condition:   Neuromuscular Disorders
    Interventions:   Device: Motriplate;   Device: Motriplate
    Sponsor:   Institut de Myologie, France
    Not yet recruiting - verified October 2009

  • Leukemia Cell Cultures for Research of New Anti-Cancer Therapies

    Condition:   Acute Leukaemia
    Interventions:   Procedure: Blood sampling;   Procedure: Bone marrow aspiration
    Sponsor:   University Hospital, Strasbourg, France
    Not yet recruiting - verified October 2009

  • Processed Meat and Colon Carcinogenesis

    Condition:   Colorectal Cancer
    Interventions:   Other: Ham;   Other: Ham + calcium;   Other: Ham + vitamin E
    Sponsors:   Institut National de la Recherche Agronomique;   Centre de Recherche en Nutrition Humaine d'Auvergne (CRNH)
    Recruiting - verified October 2009

  • Dose Ranging Study of Celivarone With Amiodarone as Calibrator for the Prevention of Implantable Cardioverter Defibrillator (ICD) Interventions or Death

    Condition:   Arrhythmia Prophylaxis
    Interventions:   Drug: Celivarone (SSR149744);   Drug: amiodarone;   Drug: placebo
    Sponsor:   Sanofi-Aventis
    Recruiting - verified November 2009

  • Study of ACT-293987 (NS-304) in Pulmonary Arterial Hypertension (PAH)

    Condition:   Pulmonary Arterial Hypertension
    Intervention:   Device: ACT-293987 (NS-304)
    Sponsor:   Actelion
    Completed - verified October 2009

  • Cost Assessment of Two Continuous Veno-venous Haemodiafiltration (CVVHDF) Methods in an Intensive Care Unit

    Condition:   Acute Renal Failure
    Intervention:   Procedure: Continuous veno-venous haemodiafiltration
    Sponsor:   Centre Hospitalier Universitaire de Saint Etienne
    Not yet recruiting - verified October 2009

  • An International Trial to Evaluate the Efficacy and Safety of SABER-Bupivacaine for Postoperative Pain Control in Patients Following Arthroscopic Shoulder Surgery

    Condition:   Postoperative Pain
    Interventions:   Drug: SABER-Bupivacaine;   Drug: Placebo SABER-Bupivacaine;   Drug: Bupivacaine HCl
    Sponsors:   Nycomed;   Durect Corporation
    Recruiting - verified October 2009

  • An International Trial to Evaluate the Efficacy and Safety of SABER-Bupivacaine for Postoperative Pain Control in Patients Undergoing Hysterectomy

    Condition:   Postoperative Pain
    Interventions:   Drug: SABER-Bupivacaine;   Drug: Placebo SABER-Bupivacaine;   Drug: Bupivacaine HCl
    Sponsors:   Nycomed;   Durect
    Recruiting - verified October 2009

  • A Post-Market Study of the AMS AdVance™ Male Sling System for the Treatment of Male Stress Urinary Incontinence

    Condition:   Urinary Incontinence, Stress
    Intervention:   Device: American Medical Systems (AMS) AdVance™ Male Sling System
    Sponsor:   American Medical Systems
    Recruiting - verified October 2009

    • Menu
    Find Paid Clinical Trials